Blog

Explore our latest insights, news, and updates in clinical pharmacology and pharmacometrics and discover new products & services we're working on to help you accelerate your drugs to market.

newest
research spotlights

Mapping the Psychedelic Brain: What Intravenous DMT Reveals About Neurochemistry and Cortical Dynamics

Meg Gonsalves February 18, 2026
blog

Modeling Monday, Part 1: Noncompartmental Analysis as the Foundation of Pharmacokinetic Insight

Meg Gonsalves February 9, 2026
research spotlights

From Mouse to Horse to Human: What Metronidazole Can Teach Us About Translating Pharmacokinetics Across Species

Meg Gonsalves January 20, 2026
updates

A Year of Science at A2-Ai: Reflections from 2025

Meg Gonsalves December 26, 2025
updates

A Message from Sunny Chapel: 2025 Year in Review

Eric Storms December 16, 2025
news

New FDA Guidance on QTc Labeling: What Drug Developers Need to Know

Meg Gonsalves December 8, 2025
research spotlights

Aligning Clinical Trials with Real-World Aging Trends

Meg Gonsalves November 20, 2025
servicescase studies

Accelerating FDA Approval with MIDD: How A2-Ai Secured a New Dose Without a Phase 3 Trial

Eric Storms November 14, 2025
tooling

Introducing reportifyr: an R-Based Open-Source Tool for Automated Reporting

Eric Storms June 27, 2025
news

MIDD - FDA Has Officially Announced Their Roadmap to Phase Out Animal Testing for Monoclonal Antibodies

Simonne Bruck April 30, 2025
services

NCA Services - Here to Help You Make Informed, Data-Driven Decisions Quickly and Accurately in Real-Time

Simonne Bruck April 1, 2025
productsservices

A2-Ai Cloud - A Cloud-Based Platform for Drug Development, Your Way

Simonne Bruck March 11, 2025
services

IND Services - We Support and Assist You in IND Applications to Streamline the FDA Approval Process

Simonne Bruck February 28, 2025